EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The DR score in RETeval™ electroretinogram system facilitates expeditious and uncomplicated early detection and assessment of diabetic polyneuropathy in clinical practice

Yukako Sugiura-Roth, Tatsuhito Himeno iD, Emi Asano-Hayami, Yuriko Asada-Yamada, Miyuka Kawai, Yuka Shibata, Tomohide Hayami, Mikio Motegi, Makoto Kato, Hiromi Nakai-Shimoda, Emiri Yura-Miura iD, Yoshiaki Morishita iD und 4 weitere

PLOS One · 2025

DOI: 10.1371/journal.pone.0336117 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, 2025. Verfasst von Yukako Sugiura-Roth und 15 weiteren Autor:innen. Beteiligte Einrichtung: Division of Diabetes, Department of Internal Medicine, Aichi Medical University School of Medicine, Nagakute, Aich, Japan. Hauptthemen laut MEDLINE: Electroretinography, Diabetic Neuropathies, Diabetic Retinopathy. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The principal aim of this investigation was to assess the utility of a novel DR score for the early detection of diabetic polyneuropathy (DPN). This score, currently integrated into the RETeval™ electroretinogram (ERG) system, is derived from parameters such as ERG wave characteristics, patient age, and pupillary response. Traditional nerve conduction studies (NCS), though valuable, have notable limitations, including the necessity for costly equipment and specialized personnel. Consequently, it was postulated that the DR score—initially devised for predicting diabetic retinopathy—might serve as a practical alternative for diagnosing DPN. This study sought to test the hypothesis that the DR score could offer a reliable means of both diagnosing DPN and estimating its severity.

Methods

The study retrospectively analyzed 82 diabetic patients admitted to Aichi Medical University Hospital between November 2016 and January 2019. ERG was performed using the RETeval™ device, and NCS was conducted to classify DPN stages according to the Baba’s Differentiation Classification (BDC) system. Multiple regression analysis and receiver operating characteristics (ROC) analysis were employed to assess the relationship between the DR score and DPN stages.

Results

Among 82 participants, 24.4% (n = 20) had no DPN (stage 0), and 75.6% (n = 62) had stage 1 or higher DPN. The DR score was significantly correlated with various clinical parameters, including nerve conduction velocities and the severity of DPN as classified by BDC stages. The regression model showed that both the DR score and age were significant predictors of DPN severity. The ROC analysis demonstrated that the DR score had a moderate ability to discriminate between no DPN and stage 1 or more of DPN, with an area under the ROC curve of 0.738.

Conclusions

In conclusion, this study involving 82 patients suggests that the DR score may be a valuable tool for the early detection and staging of DPN, potentially offering a more accessible and cost-effective alternative to traditional NCS, with significant implications for improving diabetic care.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ElectroretinographyDiabetic NeuropathiesDiabetic RetinopathyHumansFemaleMaleMiddle AgedRetrospective StudiesAgedEarly DiagnosisROC CurveAdultNeural Conduction

Autor:innen und Institutionen

  • Division of Diabetes, Department of Internal Medicine, Aichi Medical University School of Medicine, Nagakute, Aich, Japan.
  • Department of Clinical Laboratory, Aichi Medical University Hospital, Nagakute, Aichi, Japan.

ORCID-Profile: Tatsuhito Himeno, Emiri Yura-Miura, Yoshiaki Morishita

Zitieren

APA

Sugiura-Roth, Y., Himeno, T., Asano-Hayami, E., Asada-Yamada, Y., Kawai, M., Shibata, Y., Hayami, T., Motegi, M., Kato, M., Nakai-Shimoda, H., Yura-Miura, E., Morishita, Y., Kondo, M., Tsunekawa, S., Nakamura, J., & Kamiya, H. (2025). The DR score in RETeval™ electroretinogram system facilitates expeditious and uncomplicated early detection and assessment of diabetic polyneuropathy in clinical practice. PLOS One. https://doi.org/10.1371/journal.pone.0336117

Vancouver

Sugiura-Roth Y, Himeno T, Asano-Hayami E, Asada-Yamada Y, Kawai M, Shibata Y, et al. The DR score in RETeval™ electroretinogram system facilitates expeditious and uncomplicated early detection and assessment of diabetic polyneuropathy in clinical practice. PLOS One. 2025. doi:10.1371/journal.pone.0336117

BibTeX
@article{SugiuraRoth2025,
  author = {Sugiura-Roth, Yukako and Himeno, Tatsuhito and Asano-Hayami, Emi and Asada-Yamada, Yuriko and Kawai, Miyuka and Shibata, Yuka and Hayami, Tomohide and Motegi, Mikio and Kato, Makoto and Nakai-Shimoda, Hiromi and Yura-Miura, Emiri and Morishita, Yoshiaki and Kondo, Masaki and Tsunekawa, Shin and Nakamura, Jiro and Kamiya, Hideki},
  title = {The DR score in RETeval™ electroretinogram system facilitates expeditious and uncomplicated early detection and assessment of diabetic polyneuropathy in clinical practice},
  journal = {PLOS One},
  year = {2025},
  doi = {10.1371/journal.pone.0336117}
}
Kostenlos starten →